University of Patras
Μελέτη των διαμεμβρανικών υποδοχέων EGFR,HER-2 και των σηματοδοτικών τους μονοπατιών που επηρεάζουν την έκφραση μορίων του εξωκυττάριου χώρου και τις λειτουργικές ιδιότητες στον καρκίνο του παχέος εντέρου
Abstract
dc:descriptionColon cancer is the third most common cancer worldwide. EGFR role is crucial in the development and progression of colon cancer. The receptor is activated by EGF binding in the extracellular region, creating homodimers and / or heterodimers with HER2. Several studies have reported an increased expression of EGFR, and HER2 in subsets of colon cancers. The main signaling pathways mediating the EGFR pathway is the Ras-Raf-MAPK, PI3K-AKT, protein kinase C, and the path of the JAK- STAT. Mutations in kRas and bRaf genes have been associated with aggressiveness and disease progression, in this type of cancer.The extracellular matrix (ECM) is a tissue structural support, but also a key regulator of cell behavior as its molecules govern the cell-cell and cell-matrix interactions. They also interact with cell surface receptors mediating the intracellular signals affecting cell growth and gene expression. Molecules such as metalloproteinases, TIMPs and proteoglycans as well as proteases, such as uPA, have been found to be involved in regulating the functional properties of tumor cells such as proliferation, apoptosis, angiogenesis, invasion and metastasis.In this study, colon cancer cells Caco-2 (wild type), DLD-1 (mutant kRas) and HT-29 (mutant bRaf) were used to investigate the signaling pathway of EGFR and its effect on the expression of several ECM molecules that may contribute to the invasive and metastatic potential of colon cancer cells. Additionally, we studied the intracellular pathways that mediate gene expression and functional properties of cancer cells.Initially it was found that the EGF-EGFR signaling is the major regulator of the EGFR expression, as well as HER2 expression. It appears that the signaling via the EFG-EGFR induces cell proliferation and invasion, excluding the cancer cells DLD-1, where the HER2 mediates the invasive capacity of these cells. Moreover, EGFR activation leads to the induction of uPA in cancer cell lines Caco-2 and HT-29, resulting in the enhancement of cell invasion. Similar result was found for the expression of MMP-7 in the HT-29 tumor cells. We also found that inhibition of EMMPRIN mediates the reduction of the proliferation of the highly metastatic tumor cells HT-29. Furthermore, the axis EGF-EGFR affects gene expression and activity of the proteasome. It is worth noting that HER2 mediates some of the cell processes, such as the invasive capacity of DLD-1 cancer cells and the expression of MT1-MMP and MT2-MMP. HER2 also mediates the expression and activity of the proteasome in HT-29 cells.The above data emphasize that EGFR and HER2 play distinct roles regarding cell properties and gene expression and also highlight the importance of EGF-EGFR signaling axis in colon cancer. Conclusively, investigation of new molecular targets against colon cancer cells may need to be developed concerning cells’ EGF-EGFR/HER2 functions, as well as colon cells’ mutations (kRas and bRaf) and ECM macromolecules expression. Such pharmaceutical molecules may be important regulators of colon cancer cells’ aggressiveness and progression.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ellina, Maria-Ioanna
- Έλληνα, Μαρία-Ιωάννα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/34680